Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.

BMC infectious diseases - 14 Mar 2024

Nzengui-Nzengui Guy Francis, Mourembou Gaël, M'boyis-Kamdem Hervé, Kombila-Koumavor Ayawa Claudine, Ndjoyi-Mbiguino Angélique

Abstract excerpt

INTRODUCTION: In 2022, the WHO reported that 29.8 million people around the world were living with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25‌ 375 people in Gabon (54% of all those living with HIV in the country). The literature reports a frequency of therapeutic failure with first-line antiretrovirals (ARVs) of between 20% and 82%. Unfortunately, data relating to the failure of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Anti-Retroviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Protease

Share to Protease Inhibitors

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 38486188
DOI: 10.1186/s12879-024-09156-9
PMCID: PMC10941465

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.PMID 38486188Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.Semantic proximity Read ↗

Prevalence and factors associated with drug resistance mutations among HIV - 1 patients failing to achieve virological suppression on second line treatment in Tanzania.Semantic proximity Read ↗

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read ↗

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda. A cross-sectional studySemantic proximity Read ↗

Resistance to Antiretroviral Treatment in Gabon: Need for Implementation of Guidelines on Antiretroviral Therapy Use and HIV-1 Drug Resistance Monitoring in Developing CountriesSemantic proximity Read ↗

Prevalence and Spectrum of HIV-1 Resistance Mutations in the Siberian Federal District.Semantic proximity Read ↗

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: A cross-sectional study.Semantic proximity Read ↗

Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya.Semantic proximity Read ↗

Current Resistance of HIV-1 Strains Isolated in Volunteer Blood Donors in Gabon.Semantic proximity Read ↗

2022 update of the drug resistance mutations in HIV-1.Semantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.